PACS Group, Inc.
NYSE:PACSFinancial - Conglomerates
+$0.41 today
- Market cap
- $7.35B
- Beta
- 0.00
- P/E (TTM)
- 23.0
- EPS (TTM)
- $1.55
Volume 0.78M
Average 0.84M
PACS Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
PACS Group, Inc.NYSE: PACS
Operating Expenses · Q2 FY2026 · quarter ended Jun 2026
Operating expenses grows, but more slowly than its trailing trend
Q2 FY2026 operating expenses of $229.13M rose 10.2% year over year, behind the +14.3% change in trailing-twelve-month operating expenses. Sequentially, it rose 104.0% from the prior quarter. Over 3 fiscal years it compounded at +70.5% a year.
Context
- Operating expenses amounted to 16.1% of revenue in FY2025, down 0.3 pp from a year earlier.
- Operating expenses increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +10.2% toward the trailing-twelve-month pace of +14.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 849.64M USD
- Year-over-year change
- +26.9%
- 4-year CAGR
- +69.1%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 849.64M | +26.9% |
| FY2024 | 2024-12-31 | 669.57M | +179.8% |
| FY2023 | 2023-12-31 | 239.3M | +39.7% |
| FY2022 | 2022-12-31 | 171.32M | +64.7% |
| FY2021 | 2021-12-31 | 103.99M | — |
Operating Expenses vs competitors
How PACS compares with its peers on the latest reported figures
- PACS's LTM Jun 2026 operating expenses of $682.35M is the 4th highest of the 11 companies compared; the peer median is $330.18M.
- Its year-over-year change of +14.3% is the 4th highest of 11, against a peer median of -1.4%.
- Operating expenses amounts to 12.3% of revenue for PACS, versus a peer median of 16.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $20.08B | +328.5% | +39.1% | 93.5% | |
| LTM Jun 2026 | $10.05B | -46.1% | +11.2% | 12.9% | |
| LTM Jun 2026 | $1.61B | +11.9% | +10.4% | 25.9% | |
| LTM Jun 2026 | $682.35M | +14.3% | +70.5% | 12.3% | |
| LTM Jun 2026 | $453.42M | +5.9% | -0.8% | 28.6% | |
| LTM Sep 2026 | $351.84M | -23.0% | +9.6% | 22.2% | |
| LTM Jun 2026 | $308.52M | -8.6% | +19.2% | 5.6% | |
| LTM Sep 2026 | $218.59M | -74.6% | +4.1% | 7.4% | |
| LTM Mar 2026 | $159.23M | -12.2% | +63.8% | 16.8% | |
| LTM Mar 2026 | $141.44M | +37.2% | -26.3% | 16.1% | |
| LTM Mar 2026 | $93.38M | +54.7% | +15.7% | 9.1% | |
| Peer median (excluding PACS) | $330.18M | -1.4% | +10.8% | 16.5% | |
Competitors are the stored peer set for PACS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.17B | 2.42B | 3.11B | 4.09B | 5.29B |
| Cost of Revenue | 979.22M | 2.02B | 2.66B | 3.3B | 4.13B |
| Gross Profit | 187.35M | 400.68M | 447.07M | 792.64M | 1.16B |
| Gross Margin | 16.1% | 16.5% | 14.4% | 19.4% | 21.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 96.83M | 149.01M | 213.66M | 343.81M | 415.07M |
| Operating Expenses | 103.99M | 171.32M | 239.3M | 669.57M | 849.64M |
| Depreciation & Amortization | 7.15M | 22.31M | 25.63M | 40.81M | 55.66M |
| EBITDA | 93.86M | 254.89M | 232.87M | 186.7M | 365.57M |
| EBITDA Margin | 8.0% | 10.5% | 7.5% | 4.6% | 6.9% |
| Operating Income | 83.36M | 229.36M | 207.77M | 123.07M | 309.6M |
| Operating Margin | 7.1% | 9.5% | 6.7% | 3.0% | 5.9% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 5.28M | 25.54M | 49.92M | 44.34M | 28.36M |
| Other Income / Expenses | (1.93M) | (22.32M) | (50.46M) | (21.52M) | (25.15M) |
| Income Before Tax | 81.43M | 207.05M | 157.32M | 101.55M | 284.45M |
| Pre-Tax Margin | 7.0% | 8.5% | 5.1% | 2.5% | 5.4% |
| Income Tax Expense | 33.48M | 56.55M | 44.44M | 46.21M | 92.99M |
| Net Income | 47.95M | 150.5M | 112.87M | 55.76M | 191.54M |
| Net Margin | 4.1% | 6.2% | 3.6% | 1.4% | 3.6% |
| EPS (Basic) | 0.32 | 1.00 | 0.75 | 0.38 | 1.23 |
| EPS (Diluted) | 0.32 | 1.00 | 0.75 | 0.38 | 1.22 |
| Weighted Avg Shares | 150.15M | 150.15M | 150.15M | 146.66M | 156.18M |
| Weighted Avg Shares (Diluted) | 150.15M | 150.15M | 150.15M | 148.57M | 156.7M |
PACS Group, Inc.
NYSE:PACS
Intrinsic Alpha fair value
Locked
Current Price
$46.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.